| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102620
Status
Published
Date of creation
2011-10-27 15:56 UTC (andrew.bowers@cbd.int)
Date of last update
2011-11-10 15:40 UTC (andrew.bowers@cbd.int)
Date of publication
2011-11-10 15:40 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
Country
  • Cuba
Contact officer for report
Coordinates
Enrique Moret Hernández
Director
Dirección de Relaciones Internacionales
Calle 18 A # 4118 e/ 41 y 47, Playa.
Ciudad de La Habana
Cuba, CP 11300
Phone:+(537) 2144256
Fax:+(537) 2144257
Email:emoret@citma.cu
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
ES
Dirección de Relaciones Internacionales del Ministerio de Ciencia, Tecnología y Medio Ambiente.
Centro Nacional de Seguridad Biológica.
Oficina de Regulación Ambiental y Seguridad Nuclear.
Dirección Jurídica. Ministerio de Ciencia, Tecnología y Medio Ambiente.
Ministerio de Salud Pública.
• Dirección Nacional de Salud Ambiental.
• Instituto de Nutrición e Higiene de los Alimentos.
Ministerio de la Agricultura.
• Centro Nacional de Sanidad Vegetal.
• Instituto de Medicina Veterinaria.
Ministerio de Comercio Exterior y la Inversión Extranjera.
Ministerio de Transporte.
Ministerio del Interior.
Ministerio de las Fuerzas Armadas Revolucionarias.
Aduana General de la República.
Centro Nacional de Toxicología.
Centro de Ingeniería Genética y Biotecnología.
Centro Nacional de Sanidad Agropecuaria.
Centro de Gestión y Educación Ambiental.               ]
Submission
10. Date of submission
2011-10-26
11. Time period covered by this report
Start date
2009
Time period covered by this report
End date
2010
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is partially in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • More than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Partially
21. Here you may provide further details on the implementation of Article 2 in your country:
ES
El país desde 1996 comenzó a desarrollar un proceso de elaboración de la base legal de la bioseguridad, en medio  de cual, se tuvo en cuenta el proceso negociador del Protocolo de Bioseguridad. Por este motivo,  la legislación resultante contiene los aspectos fundamentales relacionados con la seguridad de la biotecnología. La característica fundamental de esta legislación, es su carácter preventivo en cuanto  a los posibles daños al medio ambiente y la salud humana que pudieran ocasionar los  OVMs; y su enfoque amplio al contemplar además de éstos, las especies exóticas y los agentes biológicos patógenos al hombre, los animales y las plantas . En tal sentido, se regulan y controlan las actividades relacionadas con el uso, la liberación, la importación, exportación, transportación , comercialización y otras que involucren agentes biológicos, especies exóticas y OVMs; incluyendo el proceso constructivo de las instalaciones con riesgo biológico.

Con independencia de la legislación específica que en materia de bioseguridad ha adoptado el país, existen otras normas jurídicas que resultan pertinentes para el caso de los Organismos vivos modificados. En este sentido resalta la legislación de sanidad vegetal, que perteneciente al Ministerio de Agricultura establece el sistema fitosanitario que tiene como objetivo proteger el territorio de la introducción de plagas que dañan a las plantas y lograr un estado fitosanitario satisfactorio mediante la prevención, localización, control y erradicación de las plagas de las plantas. Incluye el servicio estatal de plantas, la determinación, el control de los plaguicidas y medios biológicos de exportación, importación, circulación interna, producción agropecuaria, forestal y de medios biológicos.

En el caso de la medicina veterinaria, también perteneciente al Ministerio de Agricultura, la legislación va encaminada a la protección de  los aspectos relacionados con la salud animal, incluyendo el control sanitario y una red de diagnóstico veterinario en todo el territorio nacional.

En materia de salud humana, el Ministerio de la Salud Pública es el Organismo de la Administración Central del Estado que traza las pautas fundamentales para la preservación de la Salud Humana: establece las medidas para la lucha contra epidemias, la inspección sanitaria estatal, la profilaxis higiénico epidemiológica, la educación para la salud y la inocuidad y seguridad alimentaria. Específicamente para los OVM se elaboró el Reglamento para el Registro Sanitario de materias primas, alimentos y aditivos alimentarios obtenidos por medios biotecnológicos, concordante con lo recomendado por el Codex Alimentarius que se encuentra en fase de aprobación.

La legislación cubana de Bioseguridad, está colocada íntegramente en el Centro de Intercambio de Información del Protocolo. No obstante, nos encontramos en una fase superior en la que se hace necesario mostrar otras normas jurídicas igualmente relevantes que inciden en el tema de los OVMs.

Cuba dispone de una entidad que, de forma especializada y permanente, se encarga de los asuntos relacionados con la Bioseguridad, denotando con ello, el alto compromiso del Estado cubano. En tal sentido, el Ministerio de Ciencia, Tecnología y Medio Ambiente, por intermedio del Centro Nacional de Seguridad Biológica, tiene una cantera de mas de 30 especialistas que, tanto en la sede central como en los territorios trabajan en función exclusiva, de las continuas demandas y requerimientos que esta disciplina  impone. A esta cantera se suman, los especialistas y técnicos que, a lo largo de todo el territorio nacional y desde sus respectivos Organismos Centrales y entidades científicas y de investigación.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • Yes
23. If you answered Yes to question 22, has this information been submitted to the BCH?
  • Partially
24. Here you may provide further details on the implementation of Article 5 in your country:
ES
Actualmente estamos en un proceso de actualización de la legislación en materia de fármacos (vinculados a los OVMs), la cual debe incorporarse al BCH.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • Yes
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Partially
28. Here you may provide further details on the implementation of Article 6 in your country:
ES
El uso confinado de OVMs en cuanto a requerimientos de Bioseguridad se refiere, está incluido en la legislación puesta a disposición del CIISB. El tema tránsito, si bien ha sido un vacío identificado desde el punto de vista de Bioseguridad, está regulado por otras autoridades como Ministerio de Transporte y Comercio Exterior.

En el caso de Cuba, las mercancías destinadas a otros Estados, que arriban a puertos cubanos en buques que contienen mercancías cuyo destino final es Cuba, se mantienen segregadas a bordo, debidamente identificadas según el tipo de mercancía. De resultar mercancías peligrosas, se identifican atendiendo a las normas internacionales adoptadas por la Organización Marítima Internacional. En el caso de ser descargadas en nuestros puertos, para ser trasbordadas a otro buque para su conducción a su destino, se mantienen en áreas debidamente identificadas y segregadas del resto de las mercancías que se operan en la instalación. El control de las cargas  transportadas, peligrosas o no, se realiza desde el punto de vista de la seguridad de éstas y de la seguridad del buque, correspondiendo a las autoridades portuarias su control sanitario y fitosanitario en lo que resulte procedente.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • Yes
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • Yes
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
ES
El país tiene en proceso una Resolución que instrumenta el procedimiento administrativo del acuerdo fundamentado previo (AFP). En este documento, se abordan los temas relativos a la notificación y la información contenida en esta, el acuse de recibo y se señala que el proceso de toma de decisiones tendrá lugar según la legislación nacional de Bioseguridad y la del resto de las autoridades que inciden en el tema OVMs.  El mecanismo para la toma de decisiones en relación con los OVMs importados para liberar al medio ambiente, resulta aplicable igualmente a los OVMs producidos en el país.

En relación con la capacidad para detectar e identificar OVMs, el país no parte de cero completamente. Si bien no existe un laboratorio acreditado y con un objeto social dentro del cual estas actividades se inserten para dar servicios a las autoridades, se dispone en algunas instituciones científicas como el Centro Nacional de Sanidad Agropecuaria y otras, de una capacidad mínima que permite la detección ante eventualidades de este tipo.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • Yes
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • Yes
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • Yes
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • Yes
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • Yes
58. How many LMOs-FFP has your country approved to date?
  • Less than 5
59. In the current reporting period, how many decisions has your country taken regarding the import of LMOs-FFP?
  • Less than 5
60. In the current reporting period, how many decisions has your country taken regarding domestic use, including placing on the market, of LMOs-FFP?
  • Less than 5
61. Has your country informed the Parties through the BCH of its decision(s) regarding import, of LMOs-FFP?
  • No
62. Has your country informed the Parties through the BCH of its decision(s) regarding domestic use, including placing on the market, of LMOs-FFP within 15 days?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
ES
El mecanismo para la toma de decisiones en materia de OVMs para uso directo como alimento humano o animal y procesamiento, es similar en cuanto al proceso de evaluación de riesgos que se necesita para su uso.

   Nota: la pregunta 55 no es aplicable para Cuba, en tanto existe un marco reglamentario nacional que siempre será el aplicable. En relación con los OVMs importados para uso como alimento humano, animal o procesamiento, el Registro Sanitario de la República de Cuba ha evaluado hasta ahora los siguientes: 
        
1. Frijol de soya S/M  Productor: Noble Brasil s.a. País: Brasil Evento: MON-04032-6(GTS 40-3-2) No. Certificado emitido Lic. 31710/10  Fecha: 9/6/10

2. Frijol de soya S/M  Productor: Bunge grain País EUA eventos: ACS-GMO5-3, GTS-40-32, MON-89788 Lic. R24048 Fecha9/6/10 Rechazo por ACS-GMO5-3

En relación con los OVMs de manufactura nacional:

El Registro Sanitario ha aprobado hasta ahora solamente como  OVM_AHAP: 2009

1. Maíz transgénico FR-bt1 Productor: Centro de Ingeniería Genética y Biotecnología  País: Cuba

Evento TC1507  No. Certificado emitido Lic.011/08 Tomo LVIII Folio O11 .

Por su parte la Centro Nacional de Seguridad Biológica, perteneciente a la Oficina de Regulación Ambiental y Seguridad Nuclear (ORASEN) aprobó, en el período que se reporta, la liberación al medio ambiente (no comercial),  del Maíz transgénico FR-bt 1 con el evento TC1507 producido por el Centro de Ingeniería Genética y Biotecnología de Cuba,   a través de la Resolución No. 37 del 2009 emitida por el Director General de la ORASEN.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • Yes
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
71. Here you may provide further details on the implementation of Article 12 in your country:
ES
En materia de Bioseguridad, Cuba cuenta con un procedimiento en fase de aprobación en el que se prevé la posibilidad de la revisión de las decisiones adoptadas en relación con los OVMs en plena concordancia con el Protocolo. En materia de salud humana, la revisión de las decisiones también procede en consonancia con la legislación vigente en la materia
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • Yes
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • Yes
82. If you answered Yes to question 81, does this mechanism include procedures for identifying experts to conduct the risk assessments?
  • Yes
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • Yes
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • Yes
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • Yes
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • Yes
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Yes, always
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • No
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • Less than 5
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • No
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • No
93. Here you may provide further details on the implementation of Article 15 in your country:
ES
En relación con la capacidad para la realización de evaluaciones de riesgo, si bien existen determinadas limitaciones desde el punto de vista tecnológico, el país posee un nivel de conocimiento y experticia alto que abarca los diferentes perfiles que inciden en una actividad de este tipo.
 
En estos momentos, estamos inmersos en un proceso de revisión y actualización de la información que sobre este tema debe incluirse en el BCH.     
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes
94.2) LMOs intended for direct use as food or feed, or for processing?
  • Yes
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes, to some extent
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • Yes
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
ES
En relación a los movimientos transfronterizos involuntarios de los organismos vivos modificados (OVM),  en el caso de Cuba,  por tratarse de una isla, estos movimientos sólo podrían ocurrir a través de instalaciones aeroportuarias y portuarias,  con el arribo o la salida de productos relacionados.

Con respecto a los desastres de origen sanitario, se aplica en particular todo lo relacionado al Control Sanitario Internacional según el Reglamento Sanitario Internacional y actualmente se elabora una nueva metodología para los análisis de peligro, vulnerabilidades y riesgos sanitarios, que incluirá la apreciación de posibles riesgos derivados del uso de OVM.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • No
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
ES
A pesar de que no existe un sistema específico para los OVMs, las normas generales pueden ser aplicables a emergencias relacionadas con estos. El Sistema de Defensa Civil en Cuba, según lo establecido por el Consejo de Defensa Nacional a través de la legislación vigente, enfrenta el proceso de Reducción de Desastres mediante la evaluación de los diferentes riesgos  y  la elaboración de planes a nivel de todos los Organismos de la Administración Central del Estado, que incluyen las medidas para prevenir, enfrentar y controlar posibles desastres.

En el caso de la sanidad vegetal, los estados de emergencia fitosanitaria son declarados por el Consejo de Estado a propuesta del Ministerio de la Agricultura en todo o en parte del territorio nacional. Una vez decparados, se ponen en vigor las estructuras previstas por el Sistema Nacional de la Defensa Civil para casos de catástrofes y se movilizan los recursos humanos y materiales para enfrentar las mismas en los diferentes niveles.

La existencia de estos mecanismos generales reforzará la necesidad de establecer un nuevo sistema de vigilancia y alerta temprana, capaz de detectar eventos de este tipo que puedan ocurrir de forma involuntaria o de forma ilícita.
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • Yes, to some extent
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • No
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
115. Here you may provide further details on the implementation of Article 18 in your country:
ES
Si bien no existe en el país un procedimiento específico para muestreo y detección de OVMs, existen entidades aisladas con una capacidad limitada que pueden brindar este servicio para cuestiones puntuales y situaciones de emergencia. En ese aspecto, se trabaja  como país  en la adopción como Norma Cubana (NC)  de las normas siguientes:

UNE_EN_ISO 21569:2005 Productos alimenticios. Métodos para detección de OGM y productos derivados. Método cualitativo basado en ácidos  nucléicos.

UNE_EN_ISO 21570:2008 Productos alimenticios. Métodos para detección de OGM y productos derivados. Método cuantitativo basado en ácidos  nucléicos.

Aunque no existen regulaciones específicas para la transportación de OVM, existen regulaciones generales para la transportación de mercancias que pueden resultar aplicables.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
123. Here you may provide further details on the implementation of Article 19 in your country:
ES
Para el Protocolo de Cartagena el país designó como Autoridad Nacional al Centro Nacional de Seguridad Biológica, en tanto es la autoridad competente para los asuntos relacionados con la Bioseguridad. No obstante existen otras autoridades competentes que inciden en el tema de los organismos vivos modificados desde diferentes puntos de vista, como el Ministerio de la Agricultura, el Ministerio de Salud Pública, el Ministerio de Comercio Exterior, Ministerio de Transporte, Aduana General de la República. En estos momentos, se trabaja en función de la coordinación institucional de todas estas autoridades  para reforzar el proceso de toma de decisiones.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available but only partially available in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available but only partially available in the BCH
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information available but not in the BCH
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information available but not in the BCH
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information available but not in the BCH
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information available but not in the BCH
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information available but only partially available in the BCH
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
128. Has your country experienced difficulties accessing or using the BCH?
  • Yes
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Yes
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
ES
Se tiene previsto completar la información referida a los resúmenes de evaluaciones de riesgo y la toma de decisiones en relación con los OVMs que se liberan al medio ambiente. Las dificultades que el punto focal del CIISB de Cuba presenta en cuanto a la conexión a internet, ha incidido negativamente a la hora de presentar la información. Paulatinamente se irá completando la información requerida conforme a nuestras prioridades y capacidades.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • Yes, always
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Bilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
138. If you answered Yes to question 137, how were these resources made available?
  • Bilateral channels
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Very difficult
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Pilot Biosafety Enabling Activity
  • Implementation of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Identification of LMOs, including their detection
  • Taking into account risks to human health
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
  • monitoreo de efectos adversos
148. Has your country developed a capacity-building strategy or action plan?
  • No
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
ES
Si bien el país identificó sus necesidades y prioridades de creación de capacidad en seguridad de la biotecnología, este ejercicio ya cuenta con algunos años, por lo que su actualización resulta indispensable. Se pretende, como parte de la coordinación institucional entre las autoridades, llevar el tema de la creación de capacidad a los efectos de armonizar este proceso y aprovechar al máximo las fuentes de financiamiento y los recursos que puedan entrar al país.  Si bien es cierto que hay alguna capacidad creada desde el punto institucional, los esfuerzos realizados no son suficientes, necesitándose de una integración para la cual los recursos deben estar disponibles. Por otra parte el desarrollo de los recursos humanos vinculados con la Bioseguridad  y la capacitación ha sido una constante, no obstante se precisa hacer énfasis en temas como identificación y monitoreo de OVMs, evaluación de riesgos entre otros. Las actividades de colaboración han estado enmarcadas esencialmente  dentro de los proyectos internacionales del sistema de Naciones Unidas, no obstante han existido iniciativas bilaterales con países como Colombia con fines de capacitación  y otras como talleres auspiciados por  la  representación  de la OPS/OMS  y con colaboración de la representación de la FAO en Cuba. Representantes cubanos han estado presentes también en importantes encuentros que han tenido lugar en este período como el Taller Internacional sobre la armonización en la detección, identificación y análisis de OVMs para países de centro y suramérica auspiciado por European Commission-Joint Reseach Center, Institute for Health and Consumer Protection  Molecular Biology and Genomics Unit.

Cuba ha creado capacidades en las actividades descritas en el punto 144 aunque se requiere continuar incrementado estas capacidades en los aspectos señaladas en el punto 147.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • No
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes, to a limited extent
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • No
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • No
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
ES
En relación con la concienciación y participación del público la Ley No. 81 "Del Medio Ambiente" regula en el artículo 4 inciso k, que el conocimiento público de las actuaciones y decisiones ambientales y la consulta de la opinión de la ciudadanía, se asegurará de la mejor manera posible con carácter ineludible. Además el artículo 9 inciso c plantea como uno de los objetivos de esta ley promover la participación ciudadana en la protección del medio ambiente y el desarrollo sostenible. Por otra parte el Decreto Ley No. 190 "De la Seguridad Biológica", en el artículo 5 inciso c regula que toda entidad tiene que  realizar una adecuada divulgación y preparación del público previo a toda liberación de agentes biológicos y sus productos, organismos y fragmentos de estos con información genética al medio ambiente.

A pesar de las acciones realizadas, se hace necerario perfeccionar los mecanismos y procedimientos para el acceso público a la información, incluyendo su  difusión mediante diferentes vías.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
ES
Cuba cuenta con mecanismos en materia de Bioseguridad, dirigidos a prevenir los movimientos ilícitos. Entre estos mecanismos, se destaca el sistema de autorizaciones que permite tener el control de todas las actividades relacionadas con OVMs en el territorio nacional. Ante el incumplimiento por parte de los importadores de alguno de estos mecanismos, existen normas jurídicas que permiten imponer sanciones administrativas que pueden ir desde multas hasta la paralización de las actividades.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Yes
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • No
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
ES
Re: Q. 136 - Canales multilaterales también
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
ES
artículo 11, pregunta 57, debe marcarse una diferencia en los destinos de los OVMs, no debe mezclarse la importación con el uso nacional pues pueden existir diferencias hacia el interior de los países.  Lo mismo sucede con el artículo 16 y la pregunta 96.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2001 or earlier
Here you may provide further details
ES
Beyond the regular national budgetary allocation (which amounts on a yearly basis to approximately 200 000 Cuban pesos just for the operation of the Regulatory Authority), in the last 4 years Cuba has developed and implemented a UNEP/GEF project  entitled "Completion and strengthening of the Cuban national biosafety framework for the effective implementation of the Cartagena Protocol "  Cost of the GEF Trust Fund                                900,091.00         47%               Co-financing:   The Cuban State                        1,018,552.00       53%
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 5 per year or more
Here you may provide further details
ES
Cuba offers, at least, 5 training courses annually on Biosafety and other specifics issues. Post-graduate courses on biosafety, including a Biosafety Master's Program and other specialized courses designed for inspectors and assessors. In addition, several courses Biosafety-related are delivered by the scientific institutions
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • Yes
Here you may provide further details
ES
Cuba is strengthening the mechanism of national coordination through the integration of all Competent Authorities that deal with LMOs. The idea of this mechanism originates from the need to integrate and organize in a single structure some isolated actions taken so far in order to draw up a strategy for the decision-making process, and parallel to this, to properly channel the needs for capacity building in biosafety.  This is for avoiding duplicity of actions concerning the resources procurement and, as a consequence, to make a better use of the international projects funds.
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 100,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Here you may provide further details
ES
Cuba has a national budget allocated on yearly bases. This budget is planned the previous year for covering the basics demands for the next period. Nevertheless, the amount allocated is limited due to our financial constraints as a consequence of the economic blockade that Cuba has been facing for more than 50 years.
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 9.b) Risk management
  • Yes
Here you may provide further details
ES
Cuba has a guideline for risk assessment and risk management of LMOs. This guideline applies to LMOs intended for confined use or for release into the environment, and covers LMOs that are plants, aquatic and non-aquatic animals, obtained through modern biotechnology techniques. In addition some guidelines on risk assessment and management applied to biological agents are developed. A guide on RA and RM for alien species is being elaborated.
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • Yes
Here you may provide further details
ES
Regarding LMOs - FFP, the Sanitary Registry of Cuba has assessed the following:             1. Frijol de soya S/M Producer: Noble Brasil s.a. País: Brasil Event: MON-04032-6(GTS 40-3-2) No. Certificate issued Lic. 31710/10  Date: 9/6/10  2. Frijol de soya S/M Producer: Bunge grain País EUA events: ACS-GMO5-3, GTS-40-32, MON-89788 Lic. R24048 Fecha9/6/10 Rejected for  ACS-GMO5-3    Regarding LMOs nationally manufactured:  The Sanitary Registry has approved only as LMOs-FFP: 2009  1. Transgenic maize FR-bt1 Producer: Centro de Ingeniería Genética y Biotecnología  Country: Cuba   Event TC1507 No. Certificate issued Lic.011/08 Tomo LVIII Folio O11 .    On the other hand, the National Center for Biosafety attached to the Office for Environmental Regulation and Nuclear Safety (ORASEN) approved the release into the environment (noncommercial),  of Transgenic maize FR-bt 1 event TC1507 Producer:  Centro de Ingeniería Genética y Biotecnología de Cuba,   pursuant the Resolution. 37 del 2009 issued by the General Director of ORASEN.
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • No
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • No
Here you may provide further details
ES
Cuba is working on the completion of the capacity for detection and identification of adverse effects of LMOs through the habilitation of specialized entities (accredited laboratories)
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Here you may provide further details
ES
Cuba does not have specific requirements on socioeconomics impacts, but the subject is reflected in a general statement in the legislation in force regarding the decision making process. A specific working group was created for this issue made up of specialist on social and economic affairs.
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
ES
No experiences to share.
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Here you may provide further details
ES
In this case Cuba has a limited capacity due to the fact that a specific system or mechanism for LMOs is not developed, but the general procedures and standards can be applicable to unintentionally released and emergencies in which LMOs are involved.
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 10 or more
Survey 19.b) Monitoring
  • None
Survey 19.c) Management / Control
  • 10 or more
Here you may provide further details
ES
Most of the staff of the National Competent Authority has been trained in risk assessment and risk management. In terms of monitoring of adverse effects no training so far.
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • No
Here you may provide further details
ES
Cuba does not have the specific infrastructure (accredited laboratories) specialized in this activity, but we have some facilities, equipment, techniques and some personnel with appropriated knowledge on this matter that can be used if necessary. Nevertheless, capacity aimed at the creation of a laboratory facility according to the international standards exclusively dedicated to identification, detection of LMOs and monitoring is strongly needed in our capacity of Importer.
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Here you may provide further details
ES
In training activities the guidance on risk assessment and risk management developed by Cuba is strongly used.
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • No
Survey 22.b) Effective
  • Yes
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • None
Here you may provide further details
ES
The training received by custom officers is aimed at general aspects on Biosafety and Cartagena protocol. Specific training on identification of LMOs is planned further.
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • One or more
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • No
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
ES
Cuba does not have a specific instrument for LMOs, but LMOs are included in a general legislation that addresses the environmental damage
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • No
Here you may provide further details
ES
The public has not been informed yet about such specific aspects, but the platform for public consultation is already made and recognized by the low. Cuba is working on a public education and participation program according to the one approved in MOP V which includes all the possible ways in which the public can be involved in the decision making process regarding LMOs , and the previous steps to be taken before people involvement.
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • not applicable
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Here you may provide further details
ES
The University of Havana and the Superior Institute of Applied Science and Technology (INSTEC) have a strong Biosafety training program. INSTEC are developing a specific training system on Biosafety which encompasses all training modalities: from pre-graduated to post graduated including the design of a Phd. In addition to that, the Universities of Cienfuegos and Holguín have joined the biosafety training activities.
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • One or more
Here you may provide further details
ES
Cuba has developed some materials on biosafety like manuals and guidance with training purposes.  In addition, a book on facilities design and a Biosafety legislation compendium are part of the training materials. The training modules on the CP and BCH developed under the Project BCH II, have been used in the off line modality in some educational activities.
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • Yes
Survey 35.b) Enforcement system
  • Yes
Here you may provide further details
ES
The strategic plan for the CP in the case of Cuba is included in all our programmatic instruments such as the Biosafety strategy and our action plan. The compliance with the tasks reflected in these documents is checked on yearly bases.
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 10 or more
Here you may provide further details
ES
We have been organized several events like conferences, seminars etc in which key aspects of the CP like public participation and education, risk assessment, identification and detection of LMOs, and socioeconomic considerations have been the core. In addition to that, specialists of the national competent authority have been invited to participate in some workshops and educational activities organized by other state bodies or agencies on biotechnology and biosafety, ethical and socioeconomic aspects.
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • None
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • BCH Central Portal
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • One or more
Here you may provide further details
ES
In the last 4 years Cuba has undertaken several initiatives on the CP and CBD itself in terms of alien species mainly. Cuba is developing 2 international GEF projects on LMOs and invasive alien species in which a strong synergy is outlined. No initiatives with other International Agreements.
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • No
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • One or more
Here you may provide further details
ES
A book on facilities design (for laboratories)  and the guidance on risk assessment are available at the (BIRC) . A compendium of our  national legislation on Biosafety is available at BCH as well.